English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Moomoo AI Dec 21, 2023 20:21

Investors overlook limited growth potential of Shenzhen Hepa...

Investors overlook limited growth potential of Shenzhen Hepalink, increasing risk of future disappointment if P/S ratio aligns with growth outlook. A hike in future revenue projections may justify current P/S ratio.
Unpleasant Surprises Could Be In Store For Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s (SZSE:002399) Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
4374 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4955
    Followers
    0
    Following
    11K
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Tesla
    TSLA
    268.460
    NVIDIA
    NVDA
    110.150
    Newsmax
    NMAX
    233.000
    4
    CoreWeave
    CRWV
    52.570
    5
    Palantir
    PLTR
    84.680
    Log In for the Full List
    Unlock Now

    Trump's comeback to the Office

    Following Trump's Policies to Seek Investment Opportunities

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

    - No more -